Onyx Biotec Limited — Updates, 07-02-2025: Press Release

Onyx Biotec Limited has secured an order valued at approximately INR 600 cr from Mankind Prime Labs Pvt Ltd for the manufacture of Dry Powder Injection. Mankind Prime Labs is a wholly-owned subsidiary of Mankind Pharma Limited. This development signifies Onyx Biotec's capability and commitment to uphold global quality standards and compliance, aiming to deliver high-quality medicines to its clients. This order could enhance Onyx's revenue streams and strengthen its position in the pharmaceutical sector. Investors should monitor this growth opportunity closely, as it reflects both the company’s operational capabilities and market demand.